| Literature DB >> 34421145 |
Vishwanath Pattan1, Balwinder Singh1, Sahar S Abdelmoneim1, Chaitra Gopinath1, Vishnu Sundaresh1.
Abstract
Lithium is the gold standard treatment for bipolar disorder. Studies have shown an association between lithium and hyperparathyroidism. However, there is limited data regarding the management of lithium-induced hyperparathyroidism. We present a clinical conundrum which physicians frequently encounter-an excellent lithium responder refractory to other treatments who developed lithium-induced hyperparathyroidism. Medical treatment with cinacalcet was successful in management of hyperparathyroidism without discontinuing lithium maintenance therapy.Entities:
Keywords: bipolar disorder; cinacalcet; hypercalcemia; hyperparathyroidism; lithium
Mesh:
Substances:
Year: 2021 PMID: 34421145 PMCID: PMC8374931
Source DB: PubMed Journal: Psychopharmacol Bull ISSN: 0048-5764